LYRA
Price
$5.23
Change
+$0.02 (+0.38%)
Updated
Apr 24, 2:31 PM EST
13 days until earnings call
TCON
Price
$1.89
Change
+$0.04 (+2.16%)
Updated
Apr 24, 6:59 PM EST
21 days until earnings call
Ad is loading...

Analysis and predictions LYRA vs TCON

Header iconLYRA vs TCON Comparison
Open Charts LYRA vs TCONBanner chart's image
Lyra Therapeutics
Price$5.23
Change+$0.02 (+0.38%)
Volume$200
CapitalizationN/A
TRACON Pharmaceuticals
Price$1.89
Change+$0.04 (+2.16%)
Volume$31.79K
CapitalizationN/A
View a ticker or compare two or three
LYRA vs TCON Comparison Chart

Loading...

LYRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TCONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
LYRA vs. TCON commentary
Apr 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a Hold and TCON is a Hold.

COMPARISON
Comparison
Apr 24, 2024
Stock price -- (LYRA: $5.21 vs. TCON: $1.85)
Brand notoriety: LYRA and TCON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 58% vs. TCON: 8%
Market capitalization -- LYRA: $311.26M vs. TCON: $4.24M
LYRA [@Biotechnology] is valued at $311.26M. TCON’s [@Biotechnology] market capitalization is $4.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $557.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 0 FA rating(s) are green whileTCON’s FA Score has 0 green FA rating(s).

  • LYRA’s FA Score: 0 green, 5 red.
  • TCON’s FA Score: 0 green, 5 red.
According to our system of comparison, LYRA is a better buy in the long-term than TCON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 4 TA indicator(s) are bullish while TCON’s TA Score has 4 bullish TA indicator(s).

  • LYRA’s TA Score: 4 bullish, 5 bearish.
  • TCON’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than TCON.

Price Growth

LYRA (@Biotechnology) experienced а -3.52% price change this week, while TCON (@Biotechnology) price change was +8.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.45%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was +1265.13%.

Reported Earning Dates

LYRA is expected to report earnings on Aug 06, 2024.

TCON is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for LYRA with price predictions.
OPEN
A.I.dvisor published
a Summary for TCON with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
LYRA($311M) has a higher market cap than TCON($4.24M). TCON YTD gains are higher at: 956.539 vs. LYRA (-0.573).
LYRATCONLYRA / TCON
Capitalization311M4.24M7,342%
EBITDAN/AN/A-
Gain YTD-0.573956.539-0%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/A39.2M-
Total DebtN/A236K-
FUNDAMENTALS RATINGS
TCON: Fundamental Ratings
TCON
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYRATCON
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend about 1 month ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LYRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
TCONDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DILAX11.500.26
+2.31%
Davis International A
VSCVX33.200.50
+1.53%
Victory Integrity Small-Cap Value A
SUSLX14.240.19
+1.35%
Lazard US Sustainable Equity Open
VCSOX24.210.29
+1.21%
VALIC Company I Intl Sclly Rspnb
ASVDX10.570.12
+1.15%
American Century Small Cap Value R6

LYRA and

Correlation & Price change

A.I.dvisor tells us that LYRA and BCYC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYRA and BCYC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
N/A
BCYC - LYRA
27%
Poorly correlated
+0.49%
ARVN - LYRA
26%
Poorly correlated
-2.58%
PTCT - LYRA
25%
Poorly correlated
-2.16%
HLVX - LYRA
25%
Poorly correlated
-1.31%
ADCT - LYRA
25%
Poorly correlated
+6.20%
More

TCON and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCON has been closely correlated with NCNA. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCON jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCON
1D Price
Change %
TCON100%
+1.65%
NCNA - TCON
86%
Closely correlated
+0.25%
RNAC - TCON
85%
Closely correlated
+12.76%
SNPX - TCON
84%
Closely correlated
+4.82%
AGEN - TCON
84%
Closely correlated
+11.96%
ALLR - TCON
80%
Closely correlated
N/A
More